Clinical Report: Impact of Shenfu Injection on 28-Day Mortality Rates in Critically Ill Sepsis Patients

Overview

This study evaluates the impact of Shenfu Injection (SFI) on 28-day mortality rates among critically ill sepsis patients. The findings suggest that SFI may have a role in improving outcomes when used alongside standard care in this patient population.

Background

Sepsis remains a leading cause of morbidity and mortality in intensive care units, necessitating effective management strategies. Traditional Chinese medicine, particularly Shenfu Injection, is being explored as a potential adjunct therapy for sepsis management. Understanding the efficacy of SFI could provide valuable insights into alternative treatment options for sepsis patients.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• Shenfu Injection is derived from traditional Chinese medicine and aims to improve organ function in sepsis.
• Previous studies have shown SFI's potential to counteract inflammation and reduce oxidative stress.
• Inconsistent results have been reported regarding the effect of SFI on 28-day mortality in sepsis patients.
• The study analyzed a large cohort of sepsis patients from an ICU database to assess the impact of SFI.
• Adverse effects and compliance with SFI treatment were monitored during the 28-day follow-up.

Clinical Implications

Clinicians should consider the potential benefits of Shenfu Injection as an adjunct therapy in sepsis management, particularly in conjunction with standard care protocols. Further research is warranted to establish definitive efficacy and safety profiles for SFI in this context.

Conclusion

The study contributes to the growing body of evidence regarding the use of Shenfu Injection in critically ill sepsis patients. Continued investigation is essential to clarify its role in improving clinical outcomes.

References

1. Critical Care (Springer), 2025 -- Xuebijing injection reduces 28-day mortality in patients with septic shock
2. Infection, 2024 -- The Relationship Between Serum Osmolality and 28-Day Mortality Rates in Sepsis Patients: Findings from a Retrospective Cohort Analysis
3. Critical Care (Springer), 2025 -- Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review
4. Intensive Care Medicine, 2018 -- The Impact of ICU Hypotension on Mortality and Morbidity Among Septic Patients During Hospitalization
5. Intensive Care Medicine, 2026 -- Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock
6. SCCM -- Surviving Sepsis Campaign Adult Guidelines
7. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026 | Intensive Care Medicine | Springer Nature Link
8. Surviving Sepsis Campaign Adult Guidelines | SCCM